» Articles » PMID: 8320323

Abnormal Growth Factor and Cytokine Expression in Dupuytren's Contracture

Overview
Journal J Clin Pathol
Specialty Pathology
Date 1993 May 1
PMID 8320323
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To analyse patterns of gene expression for peptide regulatory factors in patients with Dupuytren's contracture.

Methods: Tissue samples (palmer fascia) from 12 patients with Dupuytren's contracture and 12 controls were studied using the reverse transcription/polymerase chain reaction (RT/PCR) technique.

Results: Tissue from patients with Dupuytren's contracture expressed a higher percentage of peptide regulatory factors than that of controls: interleukin-1 alpha (83% v 16%; p < 0.01); interleukin-1 beta (66% v 8%; p < 0.01); transforming growth factor beta (75% v 25%; p < 0.02); and basic fibroblast growth factor (66% v 25%; p < 0.05). Platelet derived growth factors alpha and beta were also expressed more commonly (66% v 33% and 25% v 16%, respectively), but these differences were not significant.

Conclusions: The increased prevalence of expression for the above mRNAs in Dupuytren's tissue is relevant as interleukin-1, basic fibroblast growth factor, and transforming growth factor beta stimulate the growth of fibroblasts and transforming growth factor beta also enhances production of collagen and other extracellular matrix proteins. Excessive local release of these peptide regulatory factors may have an important role in the pathogenesis of Dupuytren's contracture.

Citing Articles

Let's Focus on the Fibrosis in Dupuytren Disease: Cell Communication Network Factor 2 as a Novel Target.

Lambi A, Morrell N, Popoff S, Benhaim P, Barbe M J Hand Surg Glob Online. 2023; 5(5):682-688.

PMID: 37790821 PMC: 10543811. DOI: 10.1016/j.jhsg.2023.06.017.


Pharmacotherapies in Dupuytren Disease: Current and Novel Strategies.

Lambi A, Popoff S, Benhaim P, Barbe M J Hand Surg Am. 2023; 48(8):810-821.

PMID: 36935324 PMC: 10440226. DOI: 10.1016/j.jhsa.2023.02.003.


Non-Oncological Radiotherapy: A Review of Modern Approaches.

Nardone V, DIppolito E, Grassi R, Sangiovanni A, Gagliardi F, De Marco G J Pers Med. 2022; 12(10).

PMID: 36294816 PMC: 9605240. DOI: 10.3390/jpm12101677.


Effect of Oral Prednisolone after Collagenase Injection for Dupuytren's Contracture: A Randomized, Controlled Trial with a 1-Year Follow-Up.

Abe Y J Hand Microsurg. 2022; 14(2):113-120.

PMID: 35983284 PMC: 9381173. DOI: 10.1055/s-0040-1709097.


Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.

Gelbard M, Rosenbloom J Endocrinol Diabetes Metab. 2021; 4(2):e00195.

PMID: 33855203 PMC: 8029506. DOI: 10.1002/edm2.195.


References
1.
Glimcher M, Smith R, Albin R, Adams J . Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am. 1981; 63(5):787-97. View

2.
LING R . THE GENETIC FACTOR IN DUPUYTREN'S DISEASE. J Bone Joint Surg Br. 1963; 45(4):709-18. View

3.
Devereux J, Haeberli P, SMITHIES O . A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984; 12(1 Pt 1):387-95. PMC: 321012. DOI: 10.1093/nar/12.1part1.387. View

4.
Postlethwaite A, Lachman L, Kang A . Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum. 1984; 27(9):995-1001. DOI: 10.1002/art.1780270905. View

5.
Leof E, Proper J, Goustin A, Shipley G, DiCorleto P, Moses H . Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A. 1986; 83(8):2453-7. PMC: 323316. DOI: 10.1073/pnas.83.8.2453. View